BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 912060)

  • 1. [Homologous anti-tissue antibodies as a factor supressing the development of malignant tumors].
    Saraeva ZM; Tereshchenko IP; Klemparskaia NN; Shal'nova GA
    Biull Eksp Biol Med; 1977 Oct; 84(10):468-71. PubMed ID: 912060
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats.
    Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukemoid reaction in BALB-c mice bearing transplanted tumors.
    Kodama T; Sendo F; Kobayashi H
    Cancer Res; 1974 Jan; 34(1):176-80. PubMed ID: 4809456
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
    Ward EC; Iglehart JD; Weinhold KJ; Bolognesi DP
    J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies against cells of methylcholanthrene sarcoma in the blood of intact mice].
    Fedorovskaia MI; Vetrova EP; Umanskii IuA
    Biull Eksp Biol Med; 1973 Jul; 76(7):78-80. PubMed ID: 4774443
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy combining tumor necrosis factor with tumor-specific antibody against Meth A sarcoma.
    Satomi N; Sakurai A; Haranaka R; Haranaka K
    J Biol Response Mod; 1989 Oct; 8(5):528-38. PubMed ID: 2677250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific adoptive and passive immunotherapy be parabiosis for syngeneic mouse and rat tumors.
    Southam CM; Bower EB; Currie VE; Babcock VI
    Ann N Y Acad Sci; 1976; 277(00):505-15. PubMed ID: 1069559
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA; Kushko LIa; Semenova-Kobzar' RA
    Vopr Onkol; 1980; 26(2):42-6. PubMed ID: 7361493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemoid reaction in BALB/c mice bearing primary tumors induced by 3-methylcholanthrene.
    Kodama T; Kawamura T; Kobayashi H
    Cancer Res; 1978 Mar; 38(3):713-5. PubMed ID: 626975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of tumor size on concomitant tumor immunity.
    Deckers PJ; Davis RC; Parker GA; Mannick JA
    Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent leukocytes.
    Dobaczewska H
    Neoplasma; 1982; 29(3):323-5. PubMed ID: 7133227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Migration capacity of tumor cells treated with immune sera].
    Lebedev KA; Kaulen DR; Khorobrykh VV; D'iakov GN; Simonova AV
    Biull Eksp Biol Med; 1977 Dec; 84(12):712-4. PubMed ID: 597608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy of newly induced murine sarcomas.
    Shu SY; Rosenberg SA
    Cancer Res; 1985 Apr; 45(4):1657-62. PubMed ID: 3872168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heterogeneity of murine sarcoma cells for transplantability due to their different susceptibilities to the lytic action of macrophages].
    Ustinov AS; Lavrovskiĭ VA
    Biull Eksp Biol Med; 1988 Mar; 105(3):322-4. PubMed ID: 3349171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of the growth of Ehrlich transplantable carcinoma in mice by antichorionic immune serum].
    Dil'man VM; Tsyrlina EV; Bulovskaia LN; Bobrov IuF
    Vopr Onkol; 1983; 29(2):62-4. PubMed ID: 6836972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 20. The antitumor action of bacterial extracts. II. Suppressive effects of extracts of E. coil on subcutaneous tumors of mouse.
    Watanabe T; Sakamoto I
    Jpn J Exp Med; 1982 Feb; 52(1):39-44. PubMed ID: 6752491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.